143 related articles for article (PubMed ID: 6977366)
41. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men.
Sabbaj J; Hoagland VL; Cook T
Scand J Infect Dis Suppl; 1986; 48():48-53. PubMed ID: 3490684
[TBL] [Abstract][Full Text] [Related]
42. Chromosomal studies in vivo and in vitro of trimethoprim and sulphamethoxazole (co-trimoxazole).
Stevenson AC; Clarke G; Patel CR; Hughes DT
Mutat Res; 1973 Feb; 17(2):255-60. PubMed ID: 4684402
[No Abstract] [Full Text] [Related]
43. Effect of co-trimoxazole on phenylalanine metabolism in man.
England JM; Coles M
Lancet; 1972 Dec; 2(7791):1341-3. PubMed ID: 4118208
[No Abstract] [Full Text] [Related]
44. [Pharmacodynamics and bacteriology in sulfamethoxazole-trimetoprim combination therapy].
Bergan T
Tidsskr Nor Laegeforen; 1972 Feb; 92(4):274-7. PubMed ID: 5016492
[No Abstract] [Full Text] [Related]
45. Effect of co-trimoxazole on the glomerular filtration rate of healthy adults.
Kainer G; Rosenberg AR
Chemotherapy; 1981; 27(4):229-32. PubMed ID: 6788457
[TBL] [Abstract][Full Text] [Related]
46. [Effect of the drug combination trimethoprim-sulfamethoxazole on the intestinal flora of man in short- and long-term administration].
Knothe H
Arzneimittelforschung; 1973 May; 23(5):704-8. PubMed ID: 4197002
[No Abstract] [Full Text] [Related]
47. [Retrospective study of bactrim tolerance(author's transl)].
Samin F; Yedo-Yedes P
Schweiz Rundsch Med Prax; 1975 Sep; 64(36):1152-4. PubMed ID: 1161759
[No Abstract] [Full Text] [Related]
48. Trimethoprim resistance in gram negative urinary pathogens.
Platt DJ; Timbury MC
Br Med J (Clin Res Ed); 1985 Feb; 290(6468):638. PubMed ID: 3918701
[No Abstract] [Full Text] [Related]
49. Therapeutic progress: trimethoprim-sulfamethoxazole.
Ruiz López R; Saavedra S; Ramírez-Ronda CH
Bol Asoc Med P R; 1984 Jul; 76(7):309-13. PubMed ID: 6332635
[No Abstract] [Full Text] [Related]
50. In vitro interactions between metronidazole or tinidazole and ampicillin, doxycycline and co-trimoxazole on the effect against anaerobic bacteria.
Bergan T; Fotland MH
Scand J Gastroenterol Suppl; 1984; 91():95-101. PubMed ID: 6610923
[TBL] [Abstract][Full Text] [Related]
51. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.
Goodhart GL
JAMA; 1984 Nov; 252(19):2748-9. PubMed ID: 6333522
[TBL] [Abstract][Full Text] [Related]
52. Treatment of urinary tract infections in Hong Kong: a comparative study of norfloxacin and co-trimoxazole.
Wong WT; Chan MK; Li MK; Wong WS; Yin PD; Cheng IK
Scand J Infect Dis Suppl; 1988; 56():22-7. PubMed ID: 3074462
[TBL] [Abstract][Full Text] [Related]
53. [Activity of the trimethoprim-sulfamethoxazole association in experimental toxoplasmosis in mice. Histochemical study].
Cellesi C; Barberi A; Terragna A
Boll Ist Sieroter Milan; 1973; 52(1):70-6. PubMed ID: 4714452
[No Abstract] [Full Text] [Related]
54. [Comparison of the in vitro antibacterial activity of trimethoprim-sulfadiazine and trimethoprim-sulfamethoxazole combinations].
Thabaut A
Therapie; 1983; 38(4):399-404. PubMed ID: 6606237
[No Abstract] [Full Text] [Related]
55. Trimethoprim-sulfamethoxazole.
Peloquin CA
N C Med J; 1983 Jul; 44(7):438. PubMed ID: 6604231
[No Abstract] [Full Text] [Related]
56. Action of cotrimoxazole on head lice.
Burns DA
Br J Dermatol; 1987 Sep; 117(3):399-400. PubMed ID: 3499928
[No Abstract] [Full Text] [Related]
57. A comparison of the susceptibilities of anaerobic bacteria to trimethoprim and sulfamethoxazole individually and in combination.
Tosolini FA; Butcher RH
Clin Ther; 1983; 5(6):629-31. PubMed ID: 6605193
[TBL] [Abstract][Full Text] [Related]
58. Trimethoprim/sulfamethoxazole and renal function in transplant patients.
Caterson RJ; Collett PV; Hood VL; Duggin GG; Horvath JS; Johnson JR; Sampson J; Tiller DJ
Clin Pharmacol Ther; 1978 May; 23(5):553-7. PubMed ID: 346293
[TBL] [Abstract][Full Text] [Related]
59. The effect of cotrimoxazole on the absorption of orally administered 6-mercaptopurine in the rat.
Burton NK; Aherne GW
Cancer Chemother Pharmacol; 1986; 16(1):83-4. PubMed ID: 3484383
[TBL] [Abstract][Full Text] [Related]
60. An in-vitro study of oral therapeutic doses of co-trimoxazole and erythromycin stearate on abnormal polymorphonuclear leucocyte migration.
Ras GJ; Anderson R
J Antimicrob Chemother; 1986 Feb; 17(2):185-93. PubMed ID: 3486178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
